Janssen Pharmaceutica Nv

Galapagos Nv

Burritt, Andrew

Veronique Birault

Martin James Inglis Andrews

Wolfgang Schmidt

Paul John Edwards

Mark Stuart Chambers

Kim Louise Hirst

Juha Andrew Clase

Angus MacLeod

Philip Huxley

Gregory Bar

Clifford John Harris

Reginald Christophe Xavier Brys

Sébastien Laurent Xavier Martina

Xueliang Tao

Friedrich Erich Karl Kroll

Andrew Burritt

Paul Edwards

Novel imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.

Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases

Novel triazolopyridine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, ECM degradation, joint degradation and/or inflammation, and others.

Triazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases

Novel imidazo[-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, arthritis, inflammation, and others.

Growing community of inventors

Hertford, United Kingdom

Veronique Birault